SynthesisNeuro-oncology2022

Prevalence of BRAFV600 in glioma and use of BRAF Inhibitors in patients with BRAFV600 mutation-positive glioma: systematic review.

Lily J Andrews et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.